US Food and Drug Administration officials want user fees to fund more staff for the cell and gene therapy program.
The Center for Biologics Evaluation and Research wants additional support staff, as well as “indirect and direct review roles.” An...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?